Accelerate Diagnostics, Inc Quarterly Entity Common Stock, Shares Outstanding from Q4 2011 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Accelerate Diagnostics, Inc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q4 2011 to Q2 2024.
  • Accelerate Diagnostics, Inc Entity Common Stock, Shares Outstanding for the quarter ending August 5, 2024 was 23.7M shares, a 64.8% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 23.7M +9.31M +64.8% Aug 5, 2024 10-Q 2024-08-08
Q1 2024 21.7M -78M -78.3% Mar 25, 2024 10-K 2024-03-29
Q3 2023 14.6M -84.5M -85.3% Nov 6, 2023 10-Q 2023-11-09
Q2 2023 14.4M -67.2M -82.4% Aug 10, 2023 10-Q 2023-08-14
Q1 2023 99.6M +31.8M +46.9% Mar 28, 2023 10-K 2023-03-31
Q3 2022 99.1M +33.5M +51.1% Nov 10, 2022 10-Q/A 2023-03-03
Q2 2022 81.6M +20.1M +32.6% Aug 11, 2022 10-Q/A 2023-03-03
Q1 2022 67.8M +6.76M +11.1% Mar 10, 2022 10-K 2022-03-14
Q3 2021 65.6M +8.57M +15% Nov 11, 2021 10-Q 2021-11-15
Q2 2021 61.5M +5.14M +9.13% Aug 4, 2021 10-Q 2021-08-11
Q1 2021 61M +5.77M +10.4% May 3, 2021 10-Q 2021-05-07
Q3 2020 57M +2.38M +4.36% Nov 3, 2020 10-Q 2020-11-06
Q2 2020 56.4M +1.84M +3.37% Aug 5, 2020 10-Q 2020-08-10
Q1 2020 55.3M +811K +1.49% May 5, 2020 10-Q 2020-05-08
Q3 2019 54.6M +446K +0.82% Nov 5, 2019 10-Q 2019-11-08
Q2 2019 54.5M +388K +0.72% Aug 5, 2019 10-Q 2019-08-08
Q1 2019 54.5M +477K +0.88% May 3, 2019 10-Q 2019-05-10
Q3 2018 54.2M -1.2M -2.16% Nov 2, 2018 10-Q 2018-11-06
Q2 2018 54.1M -1.17M -2.12% Aug 3, 2018 10-Q 2018-08-07
Q1 2018 54M +1.95M +3.74% May 4, 2018 10-Q 2018-05-10
Q3 2017 55.4M +3.96M +7.7% Nov 1, 2017 10-Q 2017-11-07
Q2 2017 55.3M +4.07M +7.94% Aug 1, 2017 10-Q 2017-08-07
Q1 2017 52M +836K +1.63% May 1, 2017 10-Q 2017-05-05
Q3 2016 51.4M +6.7M +15% Nov 7, 2016 10-Q 2016-11-09
Q2 2016 51.2M +6.51M +14.5% Aug 4, 2016 10-Q 2016-08-08
Q1 2016 51.2M +6.54M +14.6% Mar 8, 2016 10-K 2016-03-09
Q3 2015 44.7M +129K +0.29% Oct 26, 2015 10-Q 2015-11-02
Q2 2015 44.7M +140K +0.31% Jul 24, 2015 10-Q 2015-07-31
Q1 2015 44.7M +2.75M +6.57% Apr 21, 2015 10-Q 2015-05-07
Q3 2014 44.6M +3.14M +7.57% Oct 27, 2014 10-Q 2014-11-04
Q2 2014 44.6M +5.68M +14.6% Jul 28, 2014 10-Q 2014-08-01
Q1 2014 41.9M +3.07M +7.91% Apr 28, 2014 10-Q 2014-05-02
Q3 2013 41.5M +16.2M +64.4% Nov 1, 2013 10-Q 2013-11-08
Q2 2013 38.9M Aug 1, 2013 10-Q 2013-08-09
Q1 2013 38.8M +27.7M +250% Mar 6, 2013 10-KT 2013-03-20
Q4 2012 25.3M +14.2M +128% Dec 5, 2012 10-Q 2012-12-14
Q3 2012 25.2M Oct 15, 2012 10-K 2012-10-26
Q1 2012 11.1M Apr 30, 2012 10-Q/A 2012-06-15
Q4 2011 11.1M Dec 9, 2011 10-Q 2011-12-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.